Effects of dietary potassium citrate supplementation on urine pH and urinary relative supersaturation of calcium oxalate and struvite in healthy dogs

American Journal of Veterinary Research

Volumn 61, Issue 4, 2000, Pages 430-435

  Stevenson, Abigail E ^a   Wrigglesworth, David J ^a   Smith, Brigitte H E ^a   Markwell, Peter J ^a  

^a WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CALCIUM OXALATE; CITRATE POTASSIUM; CITRIC ACID; MAGNESIUM; PHOSPHATE; STRUVITE;

ANIMAL EXPERIMENT; ARTICLE; CALCIUM URINE LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOG; DRUG EFFECT; FEMALE; MALE; NONHUMAN; RELATIVE DENSITY; URINALYSIS; URINE PH; URINE VOLUME;

ANIMALIA; CANIS FAMILIARIS;

EID: 0034022722     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2000.61.430     Document Type: Article

References (29)

1. Robertson WG. Urinary tract calculi. In: Nordin BEC, Need AG, Morris HA, eds. Metabolic bone and stone disease. 3rd ed. Churchill Livingstone Inc, 1993;249-311.
2. Parivar F, Low RK, Stoller ML. The influence of diet on urinary stone disease. J Urol 1996;155:432-440.
3. Butz M. Rational prevention of calcium urolithiasis. Urol Int 1986;41:387-392.
4. Simpson DE Citrate excretion: a window on renal metabolism. Am J Physiol 1983;244:F223-F234.
5. Lulich JP, Osborne CA, Polzin DJ, et al. Calcium oxalate urolithiasis, in Proceedings. 16th Annu WALTHAM/OSU Symp Treatment Small Anim Dis Nephrol Urol 1992;69-74.
6. Osborne CA, Poffenbarger EM, Klausner JS, et al. Etiopathogenesis, clinical manifestations and management of canine calcium oxalate uroliths. Vet Clin North Am Small Anim Pract 1986;16: 133-170.
7. Osborne CA, Lulich JP, Bartges JW, et al. Canine and feline urolithiasis: relationship of etiopathogenesis to treatment and prevention. In: Osborne CA, Finco DR, eds. Canine and feline nephrology and urology. Philadelphia: Lea & Febiger, 1995;798-888.
8. Lulich JP, Osborne CA. Canine calcium oxalate uroliths. In: Bonagura JD, ed. Kirk's current veterinary therapy XI1. Small animal practice. London: WB Saunders Co, 1995;992-996.
9. Pet Food Manufacturers' Association. Summary of information to support the inclusion of the following additives as "urine pH modifying substances' in relation to the list of nutritional purposes being drawn up under directive 93/74: ammonium chloride; DL-Methionine; calcium sulphate; potassium citrate; calcium carbonate. Resume dossier. London, UK 1995;61-67.
10. Her Majesty's Stationary Office (HMSO). Feeding stuffs sampling and analysis regulations. London: The HMSO Publications Centre, Reference number SI;1982 Document number 1144 1991;1-78.
11. Sweeney RA. Generic combustion method for the determination of crude protein in feeds: collaborative study. J Anal Chem 1989;72:770-774.
12. Stevenson AE, Smith BHE, Markwell PJ. A system to monitor urinary tract health in thedog. J Nutr 1998;28:12S, 2761S-2762S.
13. Stevenson AE, Smith BHE, Markwell PJ. Use of computer systems to monitor urinary tract health in cats, in Proceedings. 6th FELASA Symp 1996;95-96.
14. Markwell PJ, Smith BHE, McCarthy KP. A non-invasive method for assessing the effect of diet on urinary calcium oxalate and struvite relative supersaturation in the cat. Anim Technol 1999;50: 61-67.
15. Werness PG, Brown CM, Smith LH, et al. Equil 2: a basic computer program for the calculation of urinary saturation. J Urol 1985;134:1242-1244.
16. Sakhaee K, Nicar M, Hill K, et al. Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kidney Int 1983;348-352.
17. Caudarella R, Dormi A, Rizzoli E. Chronic treatment with potassium citrate in recurrent calcium urolithiasis, in Proceedings. VIII Int Symp Urolithiasis 1996;496-497.
18. Lindberg J, Cole FE, Neusetzer S. Treatment of calcium oxalate stone formers with potassium citrate, in Proceedings. VIII Int Symp Urolithiasis 1996;490-491.
19. Pak CYC, Fuller C, Sakhaee K, et al. Long-term treatment of calcium nephrolithiasis with potassium citrate. J Urol 1985;134:11-19.
20. Berg C, Larsson L, Tiselius HG. The effects of a single evening dose of alkaline citrate on urine composition and calcium stone formation. J Urol 1992;148:979-985.
21. Whalley NA, Meyers AM, Martins M, et al. Long-term effects of potassium citrate therapy on the formation of new stones in groups of recurrent stone formers with hypocitraturia. Br J Urol 1996;78:10-14.
22. Fuselier HA, Moore K, Lindberg J, et al. Agglomeration inhibition reflected stone-forming activity during long-term potassium citrate therapy in calcium stone formers. Urology 1998;52:988-994.
23. Lulich JP, Osborne CA, Nagode LA, et al. Evaluation of urine and serum metabolites in miniature Schnauzers with calcium oxalate urolithiasis. Am J Vet Res 1991;52:1583-1590.
24. Kok DJ, lestra JA, Doorenbos CJ, et al. The effects of dietary excesses in animal protein and in sodium on the composition and the crystallisation kinetics of calcium oxalate monohydrate in urines of healthy men. J Clin Endocrinol Metab 1990;71:861-867
25. Murayama T, Taguchi T. The role of the diurnal variation of urinary pH in determining stone compositions. J Urol 1993;150: 1437-1439.
26. Ogawa Y. Impact of sodium-potassium citrate on the diurnal variations in urinary calcium oxalate and calcium phosphate saturation levels in normal individuals. J Urol 1994;76:136-141.
27. Ogawa Y, Takahashi S, Kitagawa R, et al. Diurnal variation in calcium-oxalate supersaturation level in normal and stone-forming urine. Jpn J Nephrol 1983;25:1127-1130.
28. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996;155:839-843.
29. Lulich JP, Osborne CA, Unger LK, et al. Prevalence of calcium oxalate uroliths in Miniature Schnauzers. Am J Vet Res 1991;52: 1579-1582.